Open access
Open access
Powered by Google Translator Translator

Daily Archives: April 1, 2021

Therapeutics and COVID-19 | WHO guideline update advises Ivermectin should only be used to treat COVID-19 within clinical trials

1 Apr, 2021 | 04:02h | UTC

Summary and Infographic: Drug treatments for covid-19: living systematic review and network meta-analysis – The BMJ

Original guideline: Therapeutics and COVID-19: living guideline – World Health Organization

News release: WHO advises that ivermectin only be used to treat COVID-19 within clinical trials – World Health Organization

Commentary: WHO joins Europe, Merck in recommending against ivermectin for COVID-19 – Reuters

 

Commentary on Twitter

https://twitter.com/ThomasAgoritsas/status/1377372928451301384

 


ERAS Guidelines for Perioperative Care for Emergency Laparotomy: Part 1—Preoperative: Diagnosis, Rapid Assessment and Optimization

1 Apr, 2021 | 03:35h | UTC

Guidelines for Perioperative Care for Emergency Laparotomy Enhanced Recovery After Surgery (ERAS) Society Recommendations: Part 1—Preoperative: Diagnosis, Rapid Assessment and Optimization – World Journal of Surgery

 


Consensus Document: Management of superficial and deep surgical site infection

1 Apr, 2021 | 03:33h | UTC

Management of superficial and deep surgical site infection: an international multidisciplinary consensus – Updates in Surgery

Related Guidelines: Centers for Disease Control and Prevention Guideline for the Prevention of Surgical Site Infection, 2017 – JAMA Surgery AND Global guidelines on the prevention of surgical site infection – World Health Organization AND Surgical site infections: prevention and treatment – National Institute for Health and Care Excellence AND APSIC guidelines for the prevention of surgical site infections – Antimicrobial Resistance & Infection Control

 


M-A: Vitamin D supplementation to prevent acute respiratory infections

1 Apr, 2021 | 03:30h | UTC

Vitamin D supplementation to prevent acute respiratory infections: a systematic review and meta-analysis of aggregate data from randomised controlled trials – The Lancet Diabetes & Endocrinology

Commentaries: Vitamin D to prevent acute respiratory infections – The Lancet Diabetes & Endocrinology AND

 


RCT: Reduced-sodium added-potassium salt substitute reduces blood pressure in hypertensive patients

1 Apr, 2021 | 03:32h | UTC

Effects of a reduced-sodium added-potassium salt substitute on blood pressure in rural Indian hypertensive patients: a randomized, double-blind, controlled trial – American Journal of Clinical Nutrition

Commentary: Salt substitution — an effective way to reduce blood pressure in rural India – The George Institute for Global Health

 

Commentaries on Twitter

https://twitter.com/Dr_WuJ/status/1376715405553590275

 


Podcast: Diagnosis and management of diabetic ketoacidosis in children

1 Apr, 2021 | 03:24h | UTC

#22: DKA: Mind the Gap! – The Cribsiders Pediatric Medicine

 

Commentary on Twitter

 


RCT: Second-line FOLFOX chemotherapy vs. active symptom control for advanced biliary tract cancer

1 Apr, 2021 | 03:21h | UTC

Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial – The Lancet Oncology

Commentary: Treating patients with advanced biliary tract cancers: Changing tactics – Cancer Research UK

 


Systematic review: Circumcision devices vs. standard surgical techniques in adolescent and adult male circumcisions

1 Apr, 2021 | 03:23h | UTC

Circumcision devices versus standard surgical techniques in adolescent and adult male circumcisions – Cochrane Library

Summary: Are circumcision devices safer or faster when compared to standard surgical circumcisions for males older than 10 years? – Cochrane Library

 


Cohort study: Association of spontaneous abortion with all cause and cause specific premature mortality

1 Apr, 2021 | 03:27h | UTC

Association of spontaneous abortion with all cause and cause specific premature mortality: prospective cohort study – The BMJ

Commentaries: Miscarriage linked to increased risk of early death – The BMJ AND Miscarriage Linked to Higher Risk for Premature Mortality – HealthDay

 

Commentary on Twitter

 


RCT: Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer

1 Apr, 2021 | 03:19h | UTC

Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer – New England Journal of Medicine (link to abstract – $ for full-text)

 


RCT: The effect of external ventricular drain tunneling length on CSF infection rate in pediatric patients

1 Apr, 2021 | 03:16h | UTC

The effect of external ventricular drain tunneling length on CSF infection rate in pediatric patients: a randomized, double-blind, 3-arm controlled trial – Journal of Neurosurgery

 

Commentary on Twitter

 


Editorial | Vaccine certificates: does the end justify the means?

1 Apr, 2021 | 03:41h | UTC

Vaccine certificates: does the end justify the means? – The Lancet Microbe

Related: Covid-19 vaccine passports will harm sustainable development – The BMJ Opinion AND Covid-19 vaccine passports and vaccine hesitancy: freedom or control? – The BMJ Opinion AND “Vaccine Passport” Certification — Policy and Ethical Considerations – New England Journal of Medicine AND Interim position paper: considerations regarding proof of COVID-19 vaccination for international travellers – World Health Organization

 


WHO: Sinopharm, Sinovac COVID-19 vaccine data show efficacy

1 Apr, 2021 | 03:58h | UTC

Sinopharm, Sinovac COVID-19 vaccine data show efficacy: WHO – Reuters

 

Commentary on Twitter

https://twitter.com/hildabast/status/1377377034180038659

 


AstraZeneca COVID vaccine 70% effective vs. B117 variant

1 Apr, 2021 | 03:55h | UTC

AstraZeneca COVID vaccine 70% effective vs B117 variant – CIDRAP

Original study: Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial – The Lancet

 

Commentary on Twitter (thread – Click for more)

 


[Press release – not published yet] Pfizer-BioNTech vaccine 100% effective against Covid-19 in adolescents

1 Apr, 2021 | 03:52h | UTC

Press release: Pfizer-BioNTech Announce Positive Topline Results Of Pivotal Covid-19 Vaccine Study In Adolescents

Commentaries: The Pfizer-BioNTech Vaccine Is Said to Be Powerfully Protective in Adolescents – The New York Times AND Covid: Children ‘well protected by Pfizer vaccine’ – BBC AND Pfizer Says COVID-19 Vaccine Shows ‘100% Efficacy’ In Adolescents – NPR AND Pfizer says its COVID-19 vaccine protects younger teens – Associated Press AND Pfizer and BioNTech say vaccine prevents Covid-19 in adolescents – STAT

 

Commentaries on Twitter

https://twitter.com/hildabast/status/1377376427239075840

 


Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study

1 Apr, 2021 | 03:43h | UTC

Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study – The BMJ

 

Commentary on Twitter

 


Bill Gates: 5 things you should know about variants

1 Apr, 2021 | 03:49h | UTC

5 things you should know about variants – GatesNotes

 

Commentary on Twitter

 


Despite Chile’s Speedy Covid-19 Vaccination Drive, Cases Soar

1 Apr, 2021 | 03:46h | UTC

Despite Chile’s Speedy Covid-19 Vaccination Drive, Cases Soar – The New York Times (free registration may be required)

 

Commentary on Twitter (thread – click for more)

 


Opinion | “Vaccine Passport” Certification — Policy and Ethical Considerations

1 Apr, 2021 | 03:40h | UTC

“Vaccine Passport” Certification — Policy and Ethical Considerations – New England Journal of Medicine

Related: Covid-19 vaccine passports will harm sustainable development – The BMJ Opinion AND Covid-19 vaccine passports and vaccine hesitancy: freedom or control? – The BMJ Opinion AND Vaccine certificates: does the end justify the means? – The Lancet Microbe AND Interim position paper: considerations regarding proof of COVID-19 vaccination for international travellers – World Health Organization

 


Opinion | COVID-19: underpowered randomized trials, or no randomized trials?

1 Apr, 2021 | 03:42h | UTC

COVID-19: underpowered randomised trials, or no randomised trials? – Trials

 

Commentary on Twitter

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.